12,597 press releases in English indexed under finance.
NEW YORK, Oct. 14, 2026 -- Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of Class A common stock of Duolingo, Inc. (NASDAQ: DUOL) between May 2, 2025 to February 26, 2026, inclusive (the "Class Period"). A...
NEW YORK, Oct. 14, 2026 -- WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of Class A common stock of Duolingo, Inc. (NASDAQ: DUOL) between May 2, 2025 to February 26, 2026, inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than December 7, 2026.
New York, New York--(October 14, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Qfin Holdings, Inc. (NASDAQ: QFIN) between March 18, 2026 and August 25, 2026, inclusive (the "Class Period"), of the important November 30, 2026 lead plaintiff deadline. SO WHAT: If you purchased Qfin securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee...
NEW YORK, Oct. 14, 2026 -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of GoDaddy Inc. (NYSE: GDDY) between September 3, 2025 and February 24, 2026, both dates inclusive (the “Class Period”), of the important October 20, 2026 lead plaintiff deadline
New York, New York--(October 14, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Beta Bionics, Inc. (NASDAQ: BBNX) between July 30, 2025 and February 24, 2026, both dates inclusive (the "Class Period"), of the important November 3, 2026 lead plaintiff deadline.SO WHAT: If you purchased Beta Bionics common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs...
NEW YORK, Oct. 14, 2026 -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Flotek Industries, Inc. (NYSE: FTK) between August 3, 2026 and August 17, 2026, both dates inclusive (the “Class Period”), of the important October 26, 2026 lead plaintiff deadline.
NEW YORK, Oct. 14, 2026 -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Qfin Holdings, Inc. (NASDAQ: QFIN) between March 18, 2026 and August 25, 2026, inclusive (the “Class Period”), of the important November 30, 2026 lead plaintiff deadline.
NEW YORK, Oct. 14, 2026 -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of AST SpaceMobile, Inc. (NASDAQ: ASTS) between March 4, 2025 and July 15, 2026, inclusive (the “Class Period”), of the important November 13, 2026 lead plaintiff deadline.
PARSIPPANY, NJ, Oct. 14, 2026 -- Interpace Biosciences, Inc. ("Interpace" or the "Company") (OTCID: IDXG) today announced that it expects preliminary, unaudited revenue for the third quarter ended September 30, 2026 to range from $10.1 million to $10.4 million.
NEW YORK, Oct. 14, 2026 -- WHY: Rosen Law Firm, a global investor rights law firm, reminds persons or entities that: (a) sold shares of Dun & Bradstreet Holdings, Inc. (NYSE: DNB) (“D&B”) common stock in the open market from May 13, 2025 through August 26, 2025; (b) exchanged shares of D&B common stock into the August 26, 2025 merger of D&B with affiliates of Clearlake Capital Group, L.P. for $9.15 per share in cash (the “Merger”); and/or (c) held shares of D&B common stock as of the May 9, 2025 Record Date for the special meeting of stockholders and whose shares were voted on, or entitled to vote on, the Merger, of the important November 10, 2026 lead plaintiff deadline.
NEW YORK, Oct. 14, 2026 -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Taboola.com Ltd. (NASDAQ: TBLA) between May 6, 2026 and August 4, 2026, both dates inclusive (the “Class Period”), of the important October 20, 2026 lead plaintiff deadline.
New York, New York--(October 14, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Doximity, Inc. (NYSE: DOCS) between August 8, 2024 and May 13, 2026, both dates inclusive (the "Class Period"), of the important November 16, 2026 lead plaintiff deadline.SO WHAT: If you purchased Doximity common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a...